# SAVICELL Corp

SAVICELL Corp is a company headquartered in Andover, MA, United States.

## Company overview

- **Legal name:** SAVICELL Corp
- **Former names in filing history:** ONLINE DISRUPTIVE TECHNOLOGIES, INC. (2010-08-10 to 2021-11-01)
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Andover, MA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001498380

## About

SAVICELL Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001498380, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2019-04-03, it reported net income of USD -3,209,210; total assets of USD 238,312 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Net income:** -$3.2M (USD -3,209,210)
- **Total assets:** $238,312 (USD 238,312)
- **Cash and equivalents:** $120,245 (USD 120,245)
- **Operating cash flow:** -$1.3M (USD -1,256,423)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$2.1M (USD -2,064,387)
- **Total assets:** $325,880 (USD 325,880)
- **Cash and equivalents:** $232,247 (USD 232,247)
- **Operating cash flow:** -$1.0M (USD -1,046,137)

### FY2016 (period ended 2016-12-31)

- **Net income:** -$2.0M (USD -1,955,691)
- **Total assets:** $559,271 (USD 559,271)
- **Cash and equivalents:** $452,376 (USD 452,376)
- **Operating cash flow:** -$1.4M (USD -1,445,523)

### FY2015 (period ended 2015-12-31)

- **Net income:** -$2.1M (USD -2,141,671)
- **Total assets:** $1.3M (USD 1,302,803)
- **Cash and equivalents:** $1.2M (USD 1,206,809)
- **Operating cash flow:** -$1.6M (USD -1,560,843)
- **Later filings:** Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2019-11-25 — period 2019-09-30 — FORM 10-Q
- Form 10-Q — filed 2019-11-05 — period 2019-06-30 — FORM 10-Q
- Form 8-K — filed 2019-11-04 — period 2019-10-25 — FORM 8K FOR OCTOBER 25, 2019.
- Form 10-Q — filed 2019-06-17 — period 2019-03-31 — FORM 10-Q
- Form 10-K — filed 2019-04-03 — period 2018-12-31 — FORM 10-K
- Form 8-K — filed 2019-03-08 — period 2019-03-04 — FORM 8K FOR MARCH 4, 2019
- Form 10-Q — filed 2019-01-04 — period 2018-09-30 — FORM 10-Q
- Form 10-Q — filed 2018-11-16 — period 2018-06-30 — FORM 10-Q
- Form 10-Q — filed 2018-09-04 — period 2018-03-31 — FORM 10-Q
- Form 8-K — filed 2018-06-28 — period 2018-06-22 — FORM 8K
- Form 10-K — filed 2018-06-04 — period 2017-12-31 — FORM 10-K
- Form 8-K — filed 2018-04-13 — period 2018-03-08 — FORM 8K FOR MARCH 2018

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/savicell-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology